1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Singulair Paediatric-Drug Insights,2014

Singulair Paediatric-Drug Insights,2014

  • June 2014
  • -
  • Delve Insight

DelveInsight’s pharmaceuticals report, “Singulair Paediatric - Drug Insights, 2014” provides Singulair Paediatric marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope
- A review of the Singulair Paediatric based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Singulair Paediatric on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2011-2015
- Qualitative and quantitative assessment of market space
- SWOT Analysis

Reasons to buy
- Evaluate the marketing status and exclusivity details of Singulair Paediatric to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Singulair Paediatric.
- API intelligence over Singulair Paediatric and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis of Singulair Paediatric.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2011-2015

Table Of Contents

Singulair Paediatric-Drug Insights,2014
- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for the Europe
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables
- Singulair Paediatric, Market, Global Sales (in USD), 2014
- Singulair Paediatric, Description
- Singulair Paediatric, Marketed Details the United States (US)
- Singulair Paediatric, Marketed Details the Europe (EU)
- Singulair Paediatric, Patent/Exclusivity Expiry (Year), 2014
- Singulair Paediatric, Patent Number Specific Patent Expiry (Year), 2014
- Singulair Paediatric, Patent Details
- Singulair Paediatric, Route of Synthesis
- Singulair Paediatric, the United States Drug Master File (US DMF), 2014
- Singulair Paediatric, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
- Singulair Paediatric, the API Manufacturers, China, 2014
- Singulair Paediatric, the API Manufacturers, India, 2014
- Singulair Paediatric, the API Manufacturers by the US DMF Status, 2014
- Singulair Paediatric, the API Manufacturers by Region, 2014
- Singulair Paediatric, the API Manufacturers by Location/Countries, 2014
- Singulair Paediatric, Generic Players, 2014
- Singulair Paediatric, Pipeline Drug Details, 2014
- Singulair Paediatric, Clinical Trials, 2014
- Singulair Paediatric, Clinical Trials by Zone, 2014
- Company Overview, 2014
- Singulair Paediatric, SWOT Analysis, 2014
- Phase III Pipeline Therapeutics, 2014

List of Figures
- Singulair Paediatric, Market, Global Sales (in million USD), 2014
- Singulair Paediatric, Global Sales % Change, 2014
- Singulair Paediatric, Patent/Exclusivity Expiry (Year), 2014
- Singulair Paediatric, Patent Number Specific Patent Expiry (Year), 2014
- Singulair Paediatric, Route of synthesis
- Singulair Paediatric, the API Manufacturers by the US DMF Status (%), 2014
- Singulair Paediatric, the API Manufacturers by Region, 2014
- Singulair Paediatric, the API Manufacturers by Location/Countries, 2014
- Singulair Paediatric, Generic Players, 2014
- Singulair Paediatric, Clinical Trials by Zone (%), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Pulmonary Arterial Hypertension (PAH) Therapeutics - Pharmaceuticals

Global Pulmonary Arterial Hypertension (PAH) Therapeutics - Pharmaceuticals

  • $ 4500
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Pulmonary Arterial Hypertension (PAH) Therapeutics in US$ Million. The Global market is analyzed by the following Drug Class and Brands: Endothelin Recepto ...

Global and Chinese Phenylephrine (CAS 59-42-7) Industry, 2017 Market Research Report

Global and Chinese Phenylephrine (CAS 59-42-7) Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The 'Global and Chinese Phenylephrine Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Phenylephrine industry with a focus on the Chinese ...

Global and Chinese Cinnarizine Industry, 2017 Market Research Report

Global and Chinese Cinnarizine Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The ’Global and Chinese Cinnarizine Industry, 2012-2022 Market Research Report’ is a professional and in-depth study on the current state of the global Cinnarizine industry with a focus on the Chinese ...


Download Unlimited Documents from Trusted Public Sources

Respiratory Treatment Market in the US

  • January 2017
    14 pages
  • Respiratory Tre...  

  • United States  

View report >

Respiratory Treatment Market in the US - Forecast

  • November 2016
    3 pages
  • Respiratory Tre...  

    Anti Rheumatic  

  • United States  

View report >

Respiratory Treatment Market

  • November 2016
    11 pages
  • Respiratory Tre...  

    Allergy Drug  

View report >

Related Market Segments :

Respiratory Treatment

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.